Abstract
One method of treating certain cancers is by amino acid depletion. The best example of this is asparaginase, which has been used to lower blood levels of asparagine, a nonessential amino acid in humans. Asparaginase has been used for years to treat acute lymphoblastic leukemia, the most common form of leukemia in children and young adults. Since most human body cells do not require asparagine for their growth and survival, whereas the leukemic cells are auxotrophic for this amino acid, this represents a targeted approach to treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lieberman I, Ove P. Biochim Biophys Acta. 1960;38:153.
Freed JJ, Sorof S. Biochem Biophys Res Commun. 1966;22(1):1.
Freed JJ, Schatz SA. Exp Cell Res. 1969;55(3):393.
Holley RW. Biochim Biophys Acta. 1967;145(2):525.
Storr JM, Burton AF. Br J Cancer. 1974;30(1):50.
Takaku H, Takase M, Abe S, et al. Int J Cancer. 1992;51(2):244.
Sugimura K, Fukuda S, Wada Y, et al. Infect Immun. 1990;58(8):2510.
Savoca KV, Davis FF, van Es T, et al. Cancer Biochem Biophys. 1984;7(3):261.
Lam TL, Wong GK, Chow HY, et al. Pigment Cell Melanoma Res. 2011;24(2):366.
Glazer ES, Stone EM, Zhu C, et al. Transl Oncol. 2011;4(3):138.
Cheng PN, Leung YC, Lo WH, et al. Cancer Lett. 2005;224(1):67.
Yau T, Cheng PN, Chan P, et al. Invest New Drugs. 2013;31(1):99.
Dillon BJ, Prieto VG, Curley SA, et al. Cancer. 2004;100(4):826.
Tang SW, Chang WH, Chao YW, et al. J Biomed Sci. 2006;13(2):233.
Curley SA, Bomalaski JS, Ensor CM, et al. Hepato-gastroenterology. 2003;50(53):1214.
Izzo F, Marra P, Beneduce G, et al. J Clin Oncol. 2004;22(10):1815.
Delman KA, Brown TD, Thomas M, et al. J Clin Oncol ASCO Annu Meet Proc. 2005;23:16S.
Yang TS, Lu SN, Chao Y, et al. Br J Cancer. 2010;103(7):954.
Szlosarek PW, Luong P, Phillips MM, et al. J Clin Oncol. 2013;31(7):e111.
Ascierto PA, Scala S, Castello G, et al. J Clin Oncol. 2005;23(30):7660.
Feun LG, Marini A, Walker G, et al. Br J Cancer. 2012;106(9):1481.
Ott PA, Carvajal RD, Pandit-Taskar N, et al. Invest New Drugs. 2013;31(2):425.
Mauldin JP, Zeinali I, Kleypas K, et al. Transl Oncol. 2012;5(1):26.
Agrawal V, Woo JH, Mauldin JP, et al. Anticancer Drugs. 2012;23(1):51.
Groneberg DA, Giersig M, Welte T, et al. Curr Drug Targets. 2006;7(6):643.
Farokhzad OC, Langer R. Adv Drug Deliv Rev. 2006;58(14):1456.
Savaraj N, You M, Wu C, et al. Curr Mol Med. 2010;10(4):405.
Kim RH, Bold RJ, Kung HJ. Autophagy. 2009;5(4):567.
You M, Savaraj N, Kuo MT, et al. Mol Cell Biochem. 2013;374(1-2):181.
Feun LG, Wu C, Lee S, et al. Proc Am Assoc Cancer Res Los Angeles CA USA. 2007;48:4042.
Li YY, Wu CW, Chen SM, et al. Proc Am Assoc Cancer Res San Diego CA USA. 2014;55:892.
Tsai WB, Aiba I, Lee SY, et al. Mol Cancer Ther. 2009;8(12):3223.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Feun, L.G. et al. (2017). l-Arginine in Cancer Therapy. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_43
Download citation
DOI: https://doi.org/10.1007/978-3-319-26009-9_43
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-26007-5
Online ISBN: 978-3-319-26009-9
eBook Packages: MedicineMedicine (R0)